{"transactions":[{"id":890691,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":65417,"kind":"person","name":"Martins Eduardo Bruno","position":1,"cik":"0001670431","reported_name":"Martins Eduardo Bruno","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T16:42:48.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":88000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":88000,"derivative":{"exercise_price":5.38,"expiration_date":"2036-02-18","underlying":"Series A Common Stock","underlying_shares":88000},"source":{"system":"sec-edgar","filing":"0001104659-26-018194","document":"tm266959-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1670431/000110465926018194/tm266959-3_4seq1.xml","form_type":"4"}},{"id":890690,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":65417,"kind":"person","name":"Martins Eduardo Bruno","position":1,"cik":"0001670431","reported_name":"Martins Eduardo Bruno","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Series A Common Stock","published_at":"2026-02-20T16:42:48.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. The RSUs shall vest over four equal annual installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":147296,"source":{"system":"sec-edgar","filing":"0001104659-26-018194","document":"tm266959-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670431/000110465926018194/tm266959-3_4seq1.xml","form_type":"4"}},{"id":907569,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":65417,"kind":"person","name":"Martins Eduardo Bruno","position":1,"cik":"0001670431","reported_name":"Martins Eduardo Bruno","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Series A Common Stock","published_at":"2026-02-12T16:06:10.000Z","date":"2026-02-10","kind":"sale","planned":false,"acquired":false,"shares":3640,"price":5.3602,"value":19511.128,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."}],"balance_after":103296,"source":{"system":"sec-edgar","filing":"0001104659-26-014272","document":"tm266207-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670431/000110465926014272/tm266207-2_4seq1.xml","form_type":"4"}},{"id":1082795,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":65417,"kind":"person","name":"Martins Eduardo Bruno","position":1,"cik":"0001670431","reported_name":"Martins Eduardo Bruno","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Series A Common Stock","published_at":"2025-07-23T16:15:22.000Z","date":"2025-07-21","kind":"sale","planned":false,"acquired":false,"shares":8277,"price":9.1346,"value":75607.0842,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."}],"balance_after":106936,"source":{"system":"sec-edgar","filing":"0001104659-25-070015","document":"tm2521574-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670431/000110465925070015/tm2521574-2_4seq1.xml","form_type":"4"}},{"id":1278763,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":65417,"kind":"person","name":"Martins Eduardo Bruno","position":1,"cik":"0001670431","reported_name":"Martins Eduardo Bruno","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-07T16:44:52.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":138000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following February 6, 2025, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":138000,"derivative":{"exercise_price":4.71,"expiration_date":"2035-02-05","underlying":"Series A Common Stock","underlying_shares":138000},"source":{"system":"sec-edgar","filing":"0001104659-25-010589","document":"tm255919-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1670431/000110465925010589/tm255919-4_4seq1.xml","form_type":"4"}},{"id":1278762,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":65417,"kind":"person","name":"Martins Eduardo Bruno","position":1,"cik":"0001670431","reported_name":"Martins Eduardo Bruno","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Series A Common Stock","published_at":"2025-02-07T16:44:52.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. The RSUs shall vest over four equal annual installments following February 6, 2025, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":115213,"source":{"system":"sec-edgar","filing":"0001104659-25-010589","document":"tm255919-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670431/000110465925010589/tm255919-4_4seq1.xml","form_type":"4"}},{"id":1449933,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":65417,"kind":"person","name":"Martins Eduardo Bruno","position":1,"cik":"0001670431","reported_name":"Martins Eduardo Bruno","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Series A Common Stock","published_at":"2024-07-23T16:06:24.000Z","date":"2024-07-19","kind":"sale","planned":false,"acquired":false,"shares":8357,"price":3.1004,"value":25910.0428,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."}],"balance_after":81213,"source":{"system":"sec-edgar","filing":"0001104659-24-081892","document":"tm2420000-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670431/000110465924081892/tm2420000-3_4seq1.xml","form_type":"4"}},{"id":1732670,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":65417,"kind":"person","name":"Martins Eduardo Bruno","position":1,"cik":"0001670431","reported_name":"Martins Eduardo Bruno","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Series A Common Stock","published_at":"2023-11-21T16:23:31.000Z","date":"2023-11-17","kind":"grant","planned":false,"acquired":true,"shares":89570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. 25% of the RSUs shall vest on July 18, 2024, with the remainder vesting in three equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":89570,"source":{"system":"sec-edgar","filing":"0001104659-23-120375","document":"tm2331048-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670431/000110465923120375/tm2331048-3_4seq1.xml","form_type":"4"}},{"id":1825852,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":65417,"kind":"person","name":"Martins Eduardo Bruno","position":1,"cik":"0001670431","reported_name":"Martins Eduardo Bruno","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T16:17:28.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":44009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option shall vest in forty-eight (48) equal monthly installments following April 20, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":44009,"derivative":{"exercise_price":13.51,"expiration_date":"2033-04-19","underlying":"Series A Common Stock","underlying_shares":44009},"source":{"system":"sec-edgar","filing":"0001104659-23-082727","document":"tm2321276-17_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1670431/000110465923082727/tm2321276-17_4seq1.xml","form_type":"4"}},{"id":1825851,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":65417,"kind":"person","name":"Martins Eduardo Bruno","position":1,"cik":"0001670431","reported_name":"Martins Eduardo Bruno","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T16:17:28.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":44009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option shall vest in forty-eight (48) equal monthly installments following April 20, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":13.51,"expiration_date":"2033-04-19","underlying":"Common Stock","underlying_shares":44009},"source":{"system":"sec-edgar","filing":"0001104659-23-082727","document":"tm2321276-17_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1670431/000110465923082727/tm2321276-17_4seq1.xml","form_type":"4"}},{"id":1825850,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":65417,"kind":"person","name":"Martins Eduardo Bruno","position":1,"cik":"0001670431","reported_name":"Martins Eduardo Bruno","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T16:17:28.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":198132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this option vested and became exercisable on February 16, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":198132,"derivative":{"exercise_price":6.36,"expiration_date":"2031-02-18","underlying":"Series A Common Stock","underlying_shares":198132},"source":{"system":"sec-edgar","filing":"0001104659-23-082727","document":"tm2321276-17_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1670431/000110465923082727/tm2321276-17_4seq1.xml","form_type":"4"}},{"id":1825849,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":65417,"kind":"person","name":"Martins Eduardo Bruno","position":1,"cik":"0001670431","reported_name":"Martins Eduardo Bruno","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T16:17:28.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":198132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this option vested and became exercisable on February 16, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":6.36,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":198132},"source":{"system":"sec-edgar","filing":"0001104659-23-082727","document":"tm2321276-17_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670431/000110465923082727/tm2321276-17_4seq1.xml","form_type":"4"}},{"id":4386450,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":65417,"kind":"person","name":"Martins Eduardo Bruno","position":1,"cik":"0001670431","reported_name":"Martins Eduardo Bruno","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Liver and Infectious Dise"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-14T19:33:46.000Z","date":"2017-03-09","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments over 48 months measured from March 9, 2017 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":30000,"derivative":{"exercise_price":11.75,"expiration_date":"2027-03-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-17-020648","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670431/000120919117020648/doc4.xml","form_type":"4"}},{"id":4602622,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":65417,"kind":"person","name":"Martins Eduardo Bruno","position":1,"cik":"0001670431","reported_name":"Martins Eduardo Bruno","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Liver and Infectious Dise"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-15T14:54:33.000Z","date":"2016-03-23","kind":"grant","acquired":true,"shares":65216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the option shares on November 1, 2016 and vest as to the remaining shares in successive equal monthly installments for the subsequent 36 months subject to Reporting Person's continuous service status as of each such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option grant was approved by Issuer's board of directors on March 22, 2016, subject to stockholder approval of an amendment of the Issuer's 2013 Equity Incentive Plan (the \"Plan\") under which the option was granted. Issuer's stockholders approved the amendment to the Plan on August 29, 2016."}],"balance_after":65216,"derivative":{"exercise_price":15.89,"expiration_date":"2026-03-23","underlying":"Common Stock","underlying_shares":65216},"source":{"system":"sec-edgar","filing":"0001209191-16-141546","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670431/000120919116141546/doc4a.xml","form_type":"4/A","original_submission_date":"2016-03-28"}}]}